Graft-versus-host-disease
A Graft versus host disease is most likely to occur or happen, when a tissue transplant does not take because the body fights the transplanted tissue. The recipient or host body rejects the tissue and attacks it.
graft-versus-host disease and finding out her cancer had returned.
A graft versus host reaction is a product of stem cells being used to treat disease and not taking to each other. Even when identical siblings have contributed, this complication can happen.
Blood transfusion graft-vs.-host disease affects mostly the blood.
Graft-versus-host disease (GVHD) can occur after a bone marrow or stem cell transplant, where the transplanted donor cells attack the recipient's tissues. It is a potentially serious complication that can develop in various types of transplants, including those for leukemia, lymphoma, and other blood disorders.
The only transplanted tissues that house enough immune cells to cause graft vs. host disease are the blood and the bone marrow.
Bone marrow graft-vs.-host disease comes in an acute and a chronic form. The acute form appears within two months of the transplant; the chronic form usually appears within three months.
T-lymphocytes to prevent development of graft versus host reactions.
The tissues most affected by bone marrow graft-vs.-host disease are the skin, the liver, and the intestines. One form or the other occurs in close to half of the patients
The risks of stem cell transplantations include infection, rejection of the transplanted cells by the recipient's immune system, graft-versus-host disease (GVHD), and potential organ damage. Additionally, there is a risk of the transplanted cells developing into tumors or causing other adverse effects.
Testing is done to diminish the likelihood of rejection after transplant, and to avoid graft-versus-host disease (GVHD) following major organ or bone marrow transplantation.